Guideline 'diagnosis and treatment of oesophageal carcinoma';Richtlijn 'diagnostiek en behandeling oesofaguscarcinoom'

Nederlands Tijdschrift voor Geneeskunde

Volumn 150, Issue 34, 2006, Pages 1877-1882

  Siersema, P D ^a,b   Rosenbrand, C J G M ^c   Bergman, J J G H M ^b,d   Van Der Gaast, A ^a,b   Goedhart, C ^b   Richel, D J ^b,d   Stassen, L P S ^e   Tilanus, H W ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Afd Maag Darm en Leverziekten ^*

^c Dutch Institute for Healthcare Improvement CBO   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e REINIER DE GRAAF HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BARRETT ESOPHAGUS; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; DYSPLASIA; ENDOSCOPIC ECHOGRAPHY; ESOPHAGUS CARCINOMA; EVIDENCE BASED PRACTICE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HEALTH CARE; MEDICAL SOCIETY; NETHERLANDS; PRACTICE GUIDELINE; PREOPERATIVE CARE; PSYCHOSOCIAL CARE; REVIEW; ULTRASOUND;

ANTINEOPLASTIC AGENTS; CARCINOMA; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; EVIDENCE-BASED MEDICINE; HUMANS; NEOPLASM STAGING; PRACTICE GUIDELINES; PROGNOSIS;

EID: 33749247410     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Wijnhoven BP, Louwman MW, Tilanus HW, Coebergh JW. Increased incidence of adenocarcinomas at the gastro-oesophageal junction in Dutch males since the 19905. Eur J Gastroenterol Hepatol. 2002;14:115-22.
2. Soest EM van, Dieleman JP, Siersema PD, Sturkenboom MCJM, Kuipers EJ. Increasing incidence of Barrett's oesophagus in the general population. Gut. 2005;54:1062-6.
3. Hage M, Siersema PD, Dekken H van, Steyerberg EW, Dees J, Kuipers EJ. Oesophageal cancer incidence and mortality in patients with long-segment Barrett's oesophagus after a mean follow-up of 12.7 years. Scand J Gastroenterol. 2004;39:1175-9.
4. Siersema PD, Verschuur EML, Homs MYV, Gaast A van der, Eijkenboom WMH, Kuipers EJ. De palliatieve behandeling van patiënten met een oesofaguscarcinoom. Ned Tijdschr Geneeskd. 2005;149:2775-82.
5. Rasanen JV, Sihvo EI, Knuuti MJ, Minn HR, Luostarinen ME, Laippala P, et al. Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction. Ann Surg Oncol. 2003;10:954-60.
6. Westreenen HL van, Westerterp M, Bossuyt PM, Pruim J, Sloof GW, Lanschot JJ van, et al. Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol. 2004;22:3805-12.
7. Weston AP, Sharma P, Topalovski M, Richards R, Cherian R, Dixon A. Long-term follow-up of Barrett's high-grade dysplasia. Am J Gastroenterol. 2000;95:1888-93.
8. Buttar NS, Wang KK, Lutzke LS, Krishnadath KK, Anderson MA. Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett's esophagus. Gastrointest Endosc. 2001;54:682-8.
9. Westerterp M, Koppert LB, Buskens CJ, Tilanus HW, Kate FJ ten, Bergman JJ, et al. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch. 2005;446:497-504.
10. Altorki N, Kent M, Ferrara C, Port J. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg. 2002;236:177-83.
11. Hulscher JB, Sandick JW van, Boer AG de, Wijnhoven BP, Tijssen JG, Fockens P, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002;347:1662-9.
12. Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346:1128-37.
13. Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL. Surgeon volume and operative mortality in the United States. N Engl J Med. 2003;349:2117-27.
14. Dudley RA, Johansen KL, Brand R, Rennie DJ, Milstein A. Selective referral to high-volume hospitals: estimating potentially avoidable deaths. JAMA. 2000;283:1159-66.
15. Malthaner R, Fenlon D. Preoperative chemotherapy for resectable thoracic esophageal cancer [Cochrane review]. Cochrane Database Syst Rev. 2003;(4);CD001556.
16. Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol. 2001;19:305-13.
17. Wong R, Malthaner R. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus [Cochrane review]. Cochrane Database Syst Rev. 2001:(2);CD002092.